A detailed history of Boothbay Fund Management, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 29,520 shares of ZLAB stock, worth $889,732. This represents 0.03% of its overall portfolio holdings.

Number of Shares
29,520
Holding current value
$889,732
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$24.29 - $38.35 $717,040 - $1.13 Million
29,520 New
29,520 $1.07 Million
Q1 2022

May 16, 2022

BUY
$27.77 - $64.4 $276,589 - $641,424
9,960 New
9,960 $438,000
Q2 2021

Aug 16, 2021

SELL
$125.11 - $180.0 $549,483 - $790,560
-4,392 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$126.27 - $191.71 $554,577 - $841,990
4,392 New
4,392 $586,000
Q4 2018

Feb 14, 2019

SELL
$14.95 - $24.72 $197,340 - $326,304
-13,200 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$17.8 - $25.35 $234,960 - $334,620
13,200 New
13,200 $257,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.95B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.